---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-102129"
form_type: "8-K"
ticker: "BTMD"
cik: "0001819253"
company_name: "biote Corp."
filed_at: "2026-03-11T23:59:59+00:00"
generated_at: "2026-05-15T14:59:21.090973+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biote Q4 revenue $46.4M; net income $2.6M; anticipates procedure growth H2 2026

## Summary
- Q4 2025 revenue $46.4M, gross margin 68.0%; net income $2.6M ($0.06 diluted EPS), down from $3.5M ($0.10) in Q4 2024.
- Full year 2025 revenue $192.2M; net income $31.6M ($0.74 diluted EPS), versus $0.05M ($0.09) in 2024.
- Adjusted EBITDA Q4 $11.7M (25.2% margin); full year adjusted EBITDA $53.5M (27.8% margin).
- CEO Bret Christensen anticipates return to procedure revenue growth in second half of 2026.
- Company rebuilding commercial sales coverage; commercial transition impacted 2025 results as expected.

## SEC filing metadata
- accession: 0001193125-26-102129
- form_type: 8-K
- ticker: BTMD
- cik: 0001819253
- company_name: biote Corp.
- filed_at: 2026-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/0001193125-26-102129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/btmd-20260311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-102129
- JSON: https://secwatch.observer/filing/0001193125-26-102129.json
- Plain text: https://secwatch.observer/filing/0001193125-26-102129.txt

## Key facts
- Earnings Releases
  biote Corp. reported Full Year 2025 results: revenue $192.2 million, net income $31.6 million, EPS $0.74 per diluted share.
  - Period: Full Year 2025
  - Revenue: $192.2 million
  - Net income: $31.6 million
  - EPS: $0.74 per diluted share
  - Result: reported results
  source text: Full Year 2025 Financial Highlights • Revenue of $192.2 million • Gross profit margin of 71.5% • Net income of $31.6 million and diluted earnings per share attributable to biote Corp. stockholders of $0.74 per diluted share, compared to net income of $0.05 million and diluted earnings per share attributable to biote Corp. stockholders of $0.09 in 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/0001193125-26-102129-index.htm
- Earnings Releases
  biote Corp. reported the fourth quarter and fiscal year ended December 31, 2025 results: revenue $46.4 million, net income $2.6 million, EPS $0.06.
  - Period: the fourth quarter and fiscal year ended December 31, 2025
  - Revenue: $46.4 million
  - Net income: $2.6 million
  - EPS: $0.06
  - Result: reported results
  source text: expansion to capture large growth opportunity Anticipate a return to procedure revenue growth in the second half of 2026 Fourth Quarter 2025 Financial Highlights • Revenue of $46.4 million • Gross profit margin of 68.0% • Net income of $2.6 million and diluted earnings per share attributable to biote Corp. stockholders of $0.06, compared to net income of $3.5
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312526102129/0001193125-26-102129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.